Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The American Journal of Managed Care|February 26, 2011
Comparison of healthcare utilization among patients treated with alcoholism medicationsTami L Mark, Leslie B Montejano, Henry R Kranzler, et al.
Alcoholism, Clinical and Experimental Research|April 9, 2010
Effects of naltrexone treatment for alcohol-related disorders on healthcare costs in an insured populationHenry R Kranzler, Leslie B Montejano, Judith J Stephenson, et al.
Alcoholism, Clinical and Experimental Research|December 5, 2008
Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patientsHelen M Pettinati, David R Gastfriend, Qunming Dong, et al.
Journal of Substance Abuse Treatment|May 24, 2014
Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studiesDaniel M Hartung, Dennis McCarty, Rongwei Fu, et al.
The Journal of Clinical Psychiatry|March 20, 2008
Early treatment response in alcohol dependence with extended-release naltrexoneDomenic A Ciraulo, Qunming Dong, Bernard L Silverman, et al.
Journal of Psychopharmacology (Oxford, England)|July 4, 2002
Cocaine-primed craving and its relationship to depressive symptomatology in individuals with cocaine dependenceIgor Elman, Katherine H Karlsgodt, David R Gastfriend, et al.
Journal of Clinical Psychopharmacology|September 18, 2007
Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatmentStephanie S O'Malley, James C Garbutt, David R Gastfriend, et al.
Journal of Studies on Alcohol. Supplement|October 15, 2005
Factorial designs in clinical trials: options for combination treatment studiesDavid J Couper, James D Hosking, Ron A Cisler, et al.
Journal of Addictive Diseases|July 5, 2005
Predictive validity of the ASAM Patient Placement Criteria for hospital utilizationEstee Sharon, Chris Krebs, Winston Turner, et al.
Pageof 5